Who actually needs TRT, what to fix first, what the TRAVERSE trial settled on heart risk, and how TRT affects hematocrit, the prostate and fertility.
50 min read
The TRT Era is a complete reference on testosterone replacement therapy for men with diagnosed hypogonadism. It covers the whole journey in one place: how testosterone works, who genuinely needs treatment, what to rule out before a prescription is written, how the formulations differ, the safety systems that need monitoring, fertility, and what happens if you stop. Every claim is tied to clinical guidelines and trials, and the guide is explicit about the line it will not cross: it is about replacement, restoring a deficient hormone toward normal, not enhancement.
What's Inside
Written for men considering, starting or already on testosterone replacement therapy, and for coaches who want to understand it properly. It explains the diagnosis, the workup, the safety systems and the fertility decisions well enough to have an informed conversation with a doctor. It is a reference on replacement in diagnosed hypogonadism, not a guide to enhancement, and it gives no personal dosing.
TRT treats a diagnosis, not a number. Hypogonadism is a clinical syndrome: consistent symptoms plus testosterone that is low on at least two early-morning fasting tests, with the cause investigated. One test is not enough, because testosterone moves with time of day, food, sleep and illness, and about 30 percent of men with a mildly low first result are normal on repeat. Guidelines also disagree on the cut-off: the Endocrine Society uses below 264 ng/dL, the AUA below 300 ng/dL, and the European guideline treats below 12 nmol/L as suggestive. LH and FSH must be drawn before treatment starts, because they separate primary testicular failure from a hypothalamic or pituitary cause, and TRT suppresses both. The Blood Test Selector builds the right panel, and the Bloodwork Analyzer reads it in context.
Many low results have a cause that can be removed before any prescription is written, and guidelines say functional causes come first. Obesity lowers testosterone and weight loss raises it; one week of five-hour nights cut daytime testosterone by 10 to 15 percent in young men; untreated severe sleep apnoea is a reason not to start TRT at all; long energy deficits and overtraining suppress the axis; and long-term opioid use is linked to hypogonadism in about 63 percent of men. High prolactin, thyroid disease, some medications and heavy alcohol all belong on the list, and so does prior anabolic steroid use, since around a quarter of ex-users were still below the normal range years later. Treating a functional low with a prescription hides the cause and turns a solvable problem into a lifelong decision. Because thyroid problems overlap so heavily with low-T symptoms, the Thyroid Assessment Engine is worth running first.
For physiological replacement in the right population, the evidence is more reassuring than its reputation, with real caveats. The TRAVERSE trial randomised 5,246 men aged 45 to 80 with, or at high risk of, cardiovascular disease, and testosterone gel was non-inferior to placebo for major adverse cardiovascular events, at 7.0 versus 7.3 percent. It did see more atrial fibrillation, pulmonary embolism and acute kidney injury, and it did not test injections, above-normal levels or young men, so it settles less than headlines suggest. Hematocrit is the most common lab problem on TRT: guidelines act at 54 percent, and routine blood donation to hide the number drains iron and misses the cause. On the prostate, trials have not shown that TRT causes cancer, but it can stimulate an existing one, so a baseline PSA and clear referral triggers matter. The Cardiac Risk Score tracks the cardiovascular side, and estradiol, hair loss and gynecomastia each get their own safety page in the guide.
Yes, and neither answer is all-or-nothing. Exogenous testosterone switches off the signals the testes need to make sperm, so high blood testosterone and zero sperm can coexist, and the AUA and ASRM advise against prescribing testosterone to men who want children now or later. Where TRT is still chosen, the fertility plan comes first: a baseline semen analysis and, ideally, banking sperm before the first dose. Conception on TRT is possible in some men, but only a semen analysis shows it, and normal-sized testicles are not proof. Stopping TRT does not guarantee normal testosterone either: recovery depends on why you were low in the first place, how long you were treated and your age, and no guideline-endorsed, one-size restart protocol exists. The full fertility physiology is covered in The Legacy Keeper, and the axis-sparing alternative for some men is covered in The Enclomiphene File.
The full TRT Era covers testosterone physiology, the complete pre-TRT workup, formulations and pharmacokinetics compared, protocol design principles, estradiol, DHT, hematocrit, heart and prostate safety, troubleshooting, sexual function, fertility preservation and support, the exit pathway and a master checklist to take into every appointment. Download the PDF for the complete reference.
This page and the full guide are for educational purposes only. They are not medical advice, a diagnosis or a prescription. Testosterone is a prescription medicine that must be started and monitored by a qualified physician after a proper diagnosis, and drug regulation differs by country; in India, medicines fall under CDSCO. This guide covers replacement therapy for diagnosed hypogonadism and does not endorse testosterone use for physique or performance. Do not start, stop or change any medication without a qualified clinician. This content is not for anyone under 18.
There is no single number: the Endocrine Society uses below 264 ng/dL and the AUA below 300 ng/dL, each confirmed on two early-morning fasting tests. Symptoms and an investigated cause matter as much as the value.
In the TRAVERSE trial of 5,246 higher-risk men, replacement-range testosterone did not increase major cardiovascular events. It did raise atrial fibrillation and pulmonary embolism rates, and it did not test injections or above-normal levels.
Guidelines act at 54 percent: treatment pauses, sleep apnoea and other causes are checked, and it restarts at a lower dose. Routine blood donation to hide the number drains iron and misses the cause.
Sometimes, but TRT often suppresses sperm production, and high blood testosterone says nothing about sperm. Guidelines advise against testosterone for men who want children, so the fertility plan comes first.
This guide is for educational purposes only and is not medical advice.
Newsletter
One email when a new guide, calculator or breakdown goes live. Nothing else.
